583 related articles for article (PubMed ID: 32545404)
1. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.
Khashchenko E; Uvarova E; Vysokikh M; Ivanets T; Krechetova L; Tarasova N; Sukhanova I; Mamedova F; Borovikov P; Balashov I; Sukhikh G
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545404
[TBL] [Abstract][Full Text] [Related]
2. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
Yue CY; Lu LK; Li M; Zhang QL; Ying CM
PLoS One; 2018; 13(8):e0203129. PubMed ID: 30153296
[TBL] [Abstract][Full Text] [Related]
3. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F
J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339
[TBL] [Abstract][Full Text] [Related]
4. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of anti-mullerian hormone and other ovarian and adrenal hormones in adult female acne.
Bansal P; Sardana K; Arora P; Khurana A; Garga UC; Sharma L
Dermatol Ther; 2020 Nov; 33(6):e13974. PubMed ID: 33185003
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
Sanke S; Chander R; Jain A; Garg T; Yadav P
JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
Hahn S; Kuehnel W; Tan S; Kramer K; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
[TBL] [Abstract][Full Text] [Related]
8. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
9. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
Nadaraja RND; Sthaneshwar P; Razali N
Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women.
Alhassan S; Elmugadam A; Elfadil GA; Abubaker N; Elfaki EM; Hamza A; Abdalhabib EK; Karar T
Int J Womens Health; 2023; 15():837-843. PubMed ID: 37275514
[TBL] [Abstract][Full Text] [Related]
12. Determining the age group-based cut-off values of serum anti-Mullerian hormone concentrations to diagnose polycystic ovary syndrome.
Timur HT; Cimrin D; Gursoy Doruk O; Dogan OE
Curr Med Res Opin; 2023 Jun; 39(6):855-863. PubMed ID: 37074782
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.
Le MT; Le VNS; Le DD; Nguyen VQH; Chen C; Cao NT
Clin Endocrinol (Oxf); 2019 Apr; 90(4):579-585. PubMed ID: 30636332
[TBL] [Abstract][Full Text] [Related]
15. Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome.
Evliyaoglu O; Imöhl M; Weiskirchen R; van Helden J
Clin Chem Lab Med; 2020 Jul; 58(8):1291-1301. PubMed ID: 32069226
[TBL] [Abstract][Full Text] [Related]
16. Assessing the androgenic and metabolic heterogeneity in polycystic ovary syndrome using cluster analysis.
Deshmukh H; Akbar S; Bhaiji A; Saeed Y; Shah N; Adeleke K; Papageorgiou M; Atkin S; Sathyapalan T
Clin Endocrinol (Oxf); 2023 Mar; 98(3):400-406. PubMed ID: 36372554
[TBL] [Abstract][Full Text] [Related]
17. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
18. Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome.
Li Y; Zhai Y; Li L; Lu Y; Su S; Liu Y; Xu Z; Xin M; Zhang Q; Cao Z
Front Endocrinol (Lausanne); 2022; 13():881740. PubMed ID: 35757414
[TBL] [Abstract][Full Text] [Related]
19. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
Barth JH; Field HP; Yasmin E; Balen AH
Eur J Endocrinol; 2010 Mar; 162(3):611-5. PubMed ID: 20008514
[TBL] [Abstract][Full Text] [Related]
20. The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome.
Moursi MO; Salem H; Ibrahim AR; Marzouk S; Al-Meraghi S; Al-Ajmi M; Al-Naimi A; Alansari L
Gynecol Endocrinol; 2023 Aug; 39(1):2247098. PubMed ID: 37573873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]